Stating Friday, August 7th at 12:00 p.m. until Monday, August 10th, at 12:00 p.m., we will be conducting a scheduled maintenance of several of our systems. During this time, some of our systems will not be available. We apologize for any inconvenience this may cause you and appreciate your patience.
News View all news
Machine learning predicts adverse drug reactions based on drugs’ in vitro pharmacology
In an effort to minimize adverse drug reactions, researchers at Harvard Medical School, the Jackson Laboratory, the Massachusetts Institute of Technology, the University of Massachusetts, Northeastern University, Oracle Health Sciences, and the Novartis Institutes for Biomedical Research studied adverse drug reaction events from post-marketing identification surveys and target-based in vitro pharmacology of more than 2,000 marketed drugs.
Sanofi, GlaxoSmithKline make coronavirus vaccine deal with U.S.
HHS and the U.S. Department of Defense (DoD) announced Friday agreements with Sanofi and GlaxoSmithKline to support advanced development, including clinical trials and large-scale manufacturing of 100 million doses of an investigational adjuvanted vaccine against COVID-19.
Pharmacy groups tell HHS that any action on rebate rule must involve fixing pharmacy DIR fees
APhA and other leading pharmacy groups said in a letter to HHS Secretary Alex Azar that any action on a prescription drug rebate rule must address escalating fees extracted by PBMs on behalf of plan sponsors in Medicare Part D.
Postmarketing safety of vaccines approved by FDA
A retrospective cohort study examined FDA-approved vaccine labels and subsequent labeling changes triggered by post-market safety concerns. The research, covering a period of 20 years ending in December 2015, included 57 vaccines—most of which were supported by large randomized controlled trials.
July 21, 2020
Chaos in pharmacy reimbursement leads to patient safety issues,…
News broke last week that the Oklahoma State Board of Pharmacy (OSBP) had fined four CVS pharmacies in the state for poor staffing and medication errors. This is a positive development for both the…0 comments
July 30, 2020
In Open Letter to the American Public, APhA Trustees Declare: “Simple Actions Save Lives”
Citing the continued rise in the numbers of confirmed COVID-19 cases, hospitalizations and deaths, the Board of Trustees of the American Pharmacists Association today urged the American public to take the simple actions that save lives: “Wash your hands often, avoid close contact through physical distancing, and wear a face covering.”
July 28, 2020
APhA Expresses Disappointment Over Absence of Temporary Provider Status Language in HEALS Act
APhA issues statement from Scott J. Knoer, MS, PharmD, FASHP, Executive Vice President and Chief Executive Officer of the American Pharmacists Association, following the release of the HEALS Act.
APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.